Cholinergic Agonists and Antagonists Flashcards
(43 cards)
Cholinergic Agonists
Direct-acting agents bind to and activate muscarinic and nicotinic receptors. Some activate both and others are selective for the muscarinic (pilocarpine and bethanecol) or nicotinic receptor. There are two types; Esters of Choline (Acetylcholine, carbachol, bethanechol, methacholine) and Naturally occurring alkaloids (Arecoline, muscarine, pilocarpine, nicotine, lobeline)
The indirect-acting agents inhibit acetylcholinesterase. These drugs are amplifiers of endogenous acetylcholine and act where acetylcholine is physiologically released.
Acetylcholine Cardiovascular Effects
Vasodilation (M3 effect).
Decrease in cardiac rate (M2 effect) and decrease in rate of conduction in the SA and the AV nodes (M2 effect). There is also a decrease in force of contraction (M2 effect). Some of these cardiovascular direct effects can be obscured by the baroreceptor reflexes.
The IV injection of a small dose of acetylcholine produces a fall in blood pressure due to vasodilation (M3 effect) usually accompanied by reflex tachycardia. Larger doses of acetylcholine cause hypotension (M3 effect) and bradycardia (M2 effect).
Acetylcholine Systemic Effects
Vasculature (endothelial cells): Release of NO and vasodilation; Decrease in BP
Eye iris: Contraction and miosis
Ciliary muscle: Contraction and accommodation of lens to near vision
Salivary/sweat/ lacrimal glands: ↑ Secretions
Bronchi: Constriction; ↑ secretions
Heart: Bradycardia, ↓ conduction velocity
GI tract: ↑ Tone, ↑ peristaltic activity, ↑ secretions; relaxation of sphincters
Urinary bladder: Contraction of detrusor muscle; relaxation of sphincter
Male reproductive tract: Erection
Uterus: Variable
Nicotinic Effects of Acetylcholine
If large doses of acetylcholine are injected after administration of atropine, acetylcholine produces nicotinic effects: an initial increase in blood pressure due to stimulation of sympathetic ganglia and consequent vasoconstriction, and a secondary rise resulting from release of catecholamines from the adrenal medulla.
Choline Esters
Choline esters are all quaternary ammonium compounds and are thus poorly absorbed and poorly distributed into the central nervous system.
They differ markedly in their susceptibility to hydrolysis by cholinesterase.
Acetylcholine is very rapidly hydrolyzed: A large IV bolus injection has a brief effect, typically 5–20 seconds, whereas IM and SC injections produce only local effects.
Methacholine, carbachol and bethanechol are more resistant to hydrolysis by cholinesterase and have longer durations of action.
Acetylcholine
(Choline Ester)
Acetylcholine has virtually no systemic therapeutic applications because of its multiplicity of actions, and its rapid hydrolysis by both acetylcholinesterase, and plasma butyrylcholinesterase.
USES
Acetylcholine is used to obtain rapid miosis after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required.
Bethanecol
(Choline Ester)
Not hydrolyzed by acetylcholinesterase. Inactivated through hydrolysis by other esterases. Little or no nicotinic actions. Strong muscarinic activity.
USES
Treatment of acute postoperative and postpartum non obstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.
ADVERSE (of any muscarinic agonist; same for all)
Causes the effects of generalized cholinergic stimulation: Sweating, salivation, flushing, low blood pressure, nausea, abdominal pain, diarrhoea, bronchospasm.
Carbachol
(Choline Ester)
Both muscarinic and nicotinic agonist. Like bethanechol, carbachol is an ester of carbamic acid, and therefore a poor substrate for acetylcholinesterase. Hydrolyzed by other esterases at much slower rate.
USES
Intraocular use for obtaining miosis during surgery.
In addition, it reduces intraocular pressure after cataract surgery.
Methacholine
(Choline Ester)
Hydrolyzed by acetylcholinesterase at considerably slower rate than acetylcholine. Almost totally resistant to hydrolysis by nonspecific cholinesterase or butyrylcholinesterase.
Predominantly muscarinic agonist. Slight nicotinic actions.
USES
Diagnosis of bronchial airway hyperreactivity in subjects who do not have clinically apparent asthma.
Natural Alkaloids
Muscarine acts almost exclusively at muscarinic receptor sites.
Arecoline acts at muscarinic and nicotinic receptors.
Pilocarpine has mainly a muscarinic action.
Present clinical use of the natural alkaloids is largely restricted to pilocarpine as a sialagogue and miotic agent.
Pilocarpine
(Natural Alkaloid)
Tertiary amine. Stable to hydrolysis by acetylcholinesterase. Partial muscarinic agonist.
USES Glaucoma
Second line agent for open angle glaucoma. (Pilocarpine was the most widely used anti-glaucoma drug before timolol was introduced).
Management of acute angle-closure glaucoma. Treatment includes several drugs: timolol, pilocarpine, apraclonidine, acetazolamide and an osmotic agent, such as oral glycerol and IV mannitol.
ADVERSE
Can enter brain and cause CNS disturbances. Stimulates sweating and salivation.
Nicotine
Nicotinic Receptor Agonists
Ganglion Stimulant: Tertiary amine. Nicotine affects the neuromuscular junction in concentrations only slightly greater than those that affect ganglia.
NICOTINE: ACTIONS
The action of nicotine is the same on both parasympathetic and sympathetic ganglia. In low doses nicotine causes ganglionic stimulation by depolarization. The initial response to nicotine therefore resembles simultaneous discharge of both the parasympathetic and the sympathetic nervous systems.
In the cardiovascular system, the effects of nicotine are mainly sympathomimetic: Nicotine produces an increase in heart rate and blood pressure due to catecholamine release from adrenergic nerve terminals and from the adrenal medulla.
In the GI and urinary tracts the effects are largely parasympathomimetic: nausea, vomiting, diarrhea, and voiding of urine are commonly observed. Nicotine also causes an initial stimulation of salivary and bronchial secretions.
At high doses nicotine causes ganglionic blockade as a consequence of prolonged depolarization. Nicotine also causes neuromuscular blockade.
USES
Nicotine is used for smoking cessation therapy.
Acute Nicotine Poisoning
Symptoms of acute, severe nicotine poisoning include: nausea, salivation, abdominal pain, vomiting, diarrhea, cold sweat, mental confusion and weakness. The blood pressure falls, the pulse is weak, rapid and irregular. Collapse may be followed by terminal convulsions. Death may occur from paralysis of respiratory muscles and/or central respiratory failure.
Nicotine is highly liposoluble. Absorption is fast via oral mucosa, lungs, GI mucosa and skin. Crosses placental membrane and is secreted in milk.
Anticholinesterases
(Indirect-Acting Cholinergic Agonists)
1. Simple alcohols bearing a quaternary ammonium group: Edrophonium (only member of this group)
2. Carbamates: Neostigmine, physostigmine and pyridostigmine.
3. Organophosphates: Echothiophate, parathion, malathion, etc.
Edrophonium
Simple alcohol bearing a quaternary ammonium group: Binds reversibly to the active site of the enzyme, thus preventing access of acetylcholine. The enzyme-inhibitor complex does not involve a covalent bond and is short-lived (2 - 10 minutes). Anticholinesterase.
USES
Diagnosis of myasthenia gravis. Because of its brief duration of action, it is not recommended for maintenance therapy in myasthenia gravis.
Used to reverse the neuromuscular block produced by non-depolarizing muscular blockers.
Carbamates
Anticholinesterase
Physostigmine, Neostigmine, and Pyridostigmine
Carbamates form a covalent bond with the enzyme. The carbamate-cholinesterase bond spontaneously hydrolyzes within 30 minutes - 6 hours. Clinical recovery occurs in several hours; only rarely in more than 24 hours.
Physostigmine
PHYSOSTIGMINE: Tertiary amine. Can enter and stimulate the CNS. Anticholinesterase; Carbamate
USES
Treatment of overdoses of anticholinergic drugs. The tertiary amine structure of physostigmine allows it to penetrate the blood-brain barrier and exert central cholinergic effects as well. NOTE: Physostigmine should not be given to a patient with suspected TCA overdose because it can aggravate depression of cardiac conduction.
ADVERSE EFFECTS
Its effects on CNS may lead to convulsions when high doses are used.
Bradycardia may occur.
Inhibition of acetylcholinesterases at the NMJ causes accumulation of acetylcholine and results in paralysis of skeletal muscle.
These effects are rarely seen with therapeutic doses.
Neostigmine
NEOSTIGMINE: Quaternary ammonium; doesn’t enter CNS. Anticholinesterase; Carbamate
USES
Reversal of effects of non-depolarizing neuromuscular blockers after surgery. Most commonly used drug for this indication.
Used for symptomatic treatment of myasthenia gravis. Pyridostigmine is most commonly used.
Prevention and treatment of postoperative distention and urinary retention.
ADVERSE EFFECTS
Salivation, flushing, low blood pressure, nausea, abdominal pain, diarrhea, bronchospasm.
Pyridostigmine
PYRIDOSTIGMINE: Anticholinesterase; Carbamate; Quaternary ammonium.
USES
Indicated for treatment of myasthenia gravis. Most commonly used anticholinesterase for this indication.
Organophosphates
Echothiophate, parathion, malathion: Anticholinesterases
Organophosphates phosphorylate the active site of the enzyme. The covalent phosphorous-enzyme bond is extremely stable. The phosphorylated enzyme complex may undergo a process called ageing which further strengthens the phosphorous-enzyme bond. If given before ageing has occurred, strong nucleophiles like PRALIDOXIME are able to split the phosphorous-enzyme bond and can be used as cholinesterase regenerator drugs for organophosphate insecticide poisoning. Once ageing has occurred, the enzyme-inhibitor complex is more difficult to split.
NOTE: All of the organophosphates, except echothiophate, are fully distributed to all parts of the body, including the CNS. Poisoning with these agents therefore includes an important component of CNS toxicity.
Echothiophate
Organophosphate: Anticholinesterase
Used for chronic open-angle glaucoma, subacute or chronic angle-closure glaucoma after iridectomy or where surgery is refused or contraindicated.
Malathion and Parathion
THIOPHOSPHATE INSECTICIDES:
Activated in the body by conversion to oxygen analogs.
Malathion is rapidly metabolized to inactive products in birds and mammals, but not in insects. It is considered safe enough for sale to the general public.
Parathion is not detoxified effectively in vertebrates; thus it is considered more dangerous than malathion to humans and livestock and is not available for general public use.
Tabun, Sarin, and Soman
ORGANOPHOSPHATE NERVE AGENTS: Anticholinesterases
Among the most potent synthetic toxic agents known.
Organ System Effects of Anticholinesterases
CNS: In low concentrations, the liposoluble cholinesterase inhibitors cause diffuse activation of the EEG and a subjective alerting response. In higher concentrations they cause generalized convulsions, which may be followed by coma and respiratory arrest.
EYE, RESPIRATORY TRACT, GI TRACT & URINARY TRACT: The effects of cholinesterase inhibitors on these systems, all of which are well innervated by the parasympathetic system, are qualitatively similar to the effects of the direct-acting cholinomimetics.
CARDIOVASCULAR SYSTEM: The cholinesterase inhibitors can increase activation in both sympathetic and parasympathetic ganglia supplying the heart and at the acetylcholine receptors on neuroeffector cells (cardiac and vascular smooth muscles) that receive cholinergic innervation.
In the heart, the effects on the parasympathetic limb predominate. Negative chronotropic, dromotropic, and inotropic effects are evoked, and cardiac output falls. The fall in cardiac output is due to bradycardia, decreased atrial contractility and reduction in ventricular contractility. The latter effect occurs as a result of prejunctional inhibition of norepinephrine release and inhibition of postjunctional sympathetic effects.
Cholinesterase inhibitors have less marked effects on vascular smooth muscle and on blood pressure than direct-acting muscarinic agonists. This is because indirect-acting drugs can modify the tone of only those vessels innervated by cholinergic nerves1 and because the net effect on vascular tone may reflect activation of both parasympathetic and sympathetic systems. Since few vascular beds receive cholinergic innervation, the cholinergic effect at vascular smooth muscle is minimal. Activation of sympathetic ganglia would tend to increase vascular resistance.
Large (toxic) doses of these drugs cause more marked bradycardia (occasionally tachycardia) and hypotension.
THE NEUROMUSCULAR JUNCTION: Low (therapeutic) concentrations moderately prolong and intensify actions of physiologically released acetylcholine. This results in increased strength of contraction, especially in muscles weakened by curare-like neuromuscular blocking agents, or by myasthenia gravis. At higher concentrations, the accumulation of acetylcholine may result in fibrillation of muscle fibers.
Some quaternary carbamate cholinesterase inhibitors, e.g. neostigmine, have an additional direct nicotinic effect at the neuromuscular junction. This may contribute to the effectiveness of these agents in the therapy of myasthenia gravis.
